MOUNTAIN VIEW, Calif., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM) announced today that Genome Research has published a paper it co-authored describing the effects of hepatitis B virus (HBV) integration into the genomes of liver cancer patients. HBV infection is a recognized risk factor for the development of liver cancer. The paper, co-authored with researchers at a leading biotechnology company, is available online at http://genome.cshlp.org/content/early/2012/01/20/gr.133926.111.abstract.
